Chronic inflammatory demyelinating polyneuropathy (CIDP) is a rare, ... Age, gender, and diagnostic criteria can affect the incidence and prevalence rates.

The clinical presentation is diverse, and various diagnostic criteria have been developed. Treatments such as immunoglobulins, corticosteroids, and plasmapheresis show partial and transient efficacy, ...

Although there are no current reliable tests and few treatments for chronic inflammatory demyelinating polyneuropathy, which affects about 40,000 individuals in the U.S., recent FDA approvals have ...